Challenges and opportunities !
Gathering experts in neurodegenerative diseases, this event will foster interactions between researchers, clinicians, biotech/medtech and pharmaceutical companies.
The first edition of “Translational neuroscience: challenges and opportunities” took place on November 20, 2017 in Paris.
This first successful event gathered 175 participants with 115 B2B meetings during the matchmaking session. Ppt and video presentations as well as testimonials are available here. Thank you for your contribution to the success of this first edition.
During this new edition, come and hear academic translational research presentations and round table discussion on biocollections and clinical data accessibility and sharing.
You will be able to meet researchers, clinicians, biotech and pharmaceutical company representatives and initiate collaborative projects.
We are looking forward to seeing you there again and make this event even more successfull.
Ali Aït-Ikhlef, Lauranne Duquenne and Karine Valeille
What to expect ?
Meet research and clinical KOLs in neurodegenerative diseases
Learn about industrial–academic research relationships and stakes
Express your assets and needs in a flash
Identify and create partnerships during the matchmaking session
About the organizers
|NeurATRIS is a French research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of nervous system diseases.|
All together NeurATRIS state-of-the-art technological platforms represent powerful tools to identify and validate efficient biomarkers for early diagnosis and novel targets for treatments aimed at modifying the progression of neuronal degeneration.
NeurATRIS gives access to its world-class preclinical / clinical facilities and cuttingedge equipment to public and private life science actors through a one-stop shop. NeurATRIS added value is to be able to offer all the continuum in translational research and development.
The unique combination of multidisciplinary expertise and state-of-the-art platforms (neuro-imaging, pharmacology, biotherapies, cell and animal models, behavior, etc.) fully dedicated to neuroscience project is unmatched in Europe.
|Medicen Paris Region is a competitiveness cluster for innovative health technologies, with national and international scope. With nearly 420 companies, research centers, universities, hospitals and local authorities as members, it aims to position the Paris region as Europe's leading health cluster. It focuses on five strategic areas: biological diagnostics, diagnostic & interventional imaging, regenerative medicine & biomaterials, digital health and translational medicine. In close collaboration with local, regional and national healthcare innovation players, Medicen Paris Region aims to:|